CNSP
NASDAQ · Pharmaceuticals
Cns Pharmaceuticals Inc
$5.24
+0.13 (+2.54%)
Open$5.29
Previous Close$5.11
Day High$5.51
Day Low$5.12
52W High$10.59
52W Low$1.90
Volume—
Avg Volume5.0K
Market Cap7.48M
P/E Ratio—
EPS$-23.14
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+714.1% upside
Current
$5.24
$5.24
Target
$42.66
$42.66
$27.73
$42.66 avg
$55.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 401.0K | 379.4K | 323.5K |
| Net Income | 137.9K | 129.6K | 106.9K |
| Profit Margin | 34.4% | 34.2% | 33.1% |
| EBITDA | 186.8K | 161.4K | 136.4K |
| Free Cash Flow | 134.0K | 130.1K | 98.1K |
| Rev Growth | +21.3% | -7.8% | +5.5% |
| Debt/Equity | 0.24 | 0.32 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |